Penn Davis Mcfarland Inc. Buys 12,085 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Penn Davis Mcfarland Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 21.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 67,547 shares of the healthcare conglomerate's stock after buying an additional 12,085 shares during the quarter. UnitedHealth Group makes up approximately 3.7% of Penn Davis Mcfarland Inc.'s portfolio, making the stock its 8th biggest position. Penn Davis Mcfarland Inc.'s holdings in UnitedHealth Group were worth $34,169,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in UNH. FLC Capital Advisors grew its holdings in shares of UnitedHealth Group by 25.6% during the fourth quarter. FLC Capital Advisors now owns 2,155 shares of the healthcare conglomerate's stock worth $1,090,000 after purchasing an additional 439 shares during the last quarter. AMI Investment Management Inc. increased its position in UnitedHealth Group by 15.0% during the fourth quarter. AMI Investment Management Inc. now owns 5,819 shares of the healthcare conglomerate's stock worth $2,944,000 after buying an additional 758 shares during the period. Strong Tower Advisory Services raised its position in UnitedHealth Group by 2.6% in the 4th quarter. Strong Tower Advisory Services now owns 19,062 shares of the healthcare conglomerate's stock valued at $9,643,000 after purchasing an additional 482 shares during the last quarter. Mechanics Bank Trust Department increased its stake in UnitedHealth Group by 5.0% in the fourth quarter. Mechanics Bank Trust Department now owns 9,350 shares of the healthcare conglomerate's stock valued at $4,730,000 after purchasing an additional 446 shares during the period. Finally, Seilern Investment Management Ltd acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $153,015,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

NYSE:UNH traded down $0.56 during trading hours on Monday, reaching $510.03. 7,462,712 shares of the company traded hands, compared to its average volume of 5,104,531. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm's 50-day moving average is $549.37 and its 200-day moving average is $563.70. The stock has a market cap of $469.37 billion, a P/E ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.83 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group's payout ratio is currently 54.72%.

Analyst Ratings Changes

Several brokerages have weighed in on UNH. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research note on Thursday, December 5th. Bank of America reduced their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research note on Wednesday, October 16th. TD Cowen raised their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a "buy" rating in a research report on Friday, October 18th. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of "Buy" and an average target price of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.